Summary: Both the quantity and avidity of anti-FcεRI and anti-IgE antibodies change over time, demonstrating that the CU-BAT is more suitable to diagnose aiCSU. In addition, the avidity of anti-FcεRI and anti-IgE antibodies do not correlate with CU-BAT and disease activ-ity, suggesting that further factors independent of anti-FcεRI and anti-IgE autoantibodies contribute to aiCSU.
No takes yet. Share an insight, caveat, or question.
Jeorg et al. (2023) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: